Showing 4 posts of 4 posts found.


BioInvent and Transgene announce positive phase 1a solid tumour trial data

May 25, 2023
Research and Development BioInvent, Oncology, Transgene, clinical trials, oncology, tumours

Sweden-based BioInvent and French Transgene, both biotech companies, have reported positive phase 1a data from a trial studying BT-001 for …

BioInvent receives $3m payment for antibodies selected by Pfizer

December 23, 2020
Research and Development BioInvent, Cancer, Pfizer

BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …

Blow for BioInvent as vascular treatment fails

July 11, 2012
Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden

Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate.  The company’s share …

Blood clot

Encouraging data for ThromboGenics and BioInvent product

May 7, 2010
BioInvent, Lovenox, ThromboGenics, VTE

An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …

Latest content